Next Article in Journal
Development of a New Type of Prolonged Release Hydrocodone Formulation Based on Egalet® ADPREM Technology Using In Vivo–In Vitro Correlation
Previous Article in Journal
Nano Delivers Big: Designing Molecular Missiles for Cancer Therapeutics
Previous Article in Special Issue
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
Review

Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults

1
Department of Pharmacy, Getafe University Hospital, Carretera Toledo Km 12,5 Getafe, Madrid, Spain
2
Department of Paediatrics, Getafe University Hospital, Carretera Toledo Km 12,5 Getafe, Madrid, Spain
*
Authors to whom correspondence should be addressed.
Pharmaceutics 2011, 3(1), 53-72; https://doi.org/10.3390/pharmaceutics3010053
Received: 16 December 2010 / Accepted: 28 January 2011 / Published: 7 February 2011
Many physiologic differences between children and adults may result in age-related changes in pharmacokinetics and pharmacodynamics. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion and activity of bile and pancreatic fluid among other factors determine the oral bioavailability of pediatric and adult populations. Anatomical, physiological and biochemical characteristics in children also affect the bioavailability of other routes of administration. Key factors explaining differences in drug distribution between the pediatric population and adults are membrane permeability, plasma protein binding and total body water. As far as drug metabolism is concerned, important differences have been found in the pediatric population compared with adults both for phase I and phase II metabolic enzymes. Immaturity of glomerular filtration, renal tubular secretion and tubular reabsorption at birth and their maturation determine the different excretion of drugs in the pediatric population compared to adults. View Full-Text
Keywords: pharmacokinetics; children; neonates; infants; bioavailability; distribution; metabolism; excretion   pharmacokinetics; children; neonates; infants; bioavailability; distribution; metabolism; excretion  
MDPI and ACS Style

Fernandez, E.; Perez, R.; Hernandez, A.; Tejada, P.; Arteta, M.; Ramos, J.T. Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics 2011, 3, 53-72. https://doi.org/10.3390/pharmaceutics3010053

AMA Style

Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics. 2011; 3(1):53-72. https://doi.org/10.3390/pharmaceutics3010053

Chicago/Turabian Style

Fernandez, Eva, Raul Perez, Alfredo Hernandez, Pilar Tejada, Marta Arteta, and Jose T. Ramos 2011. "Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults" Pharmaceutics 3, no. 1: 53-72. https://doi.org/10.3390/pharmaceutics3010053

Find Other Styles

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop